Hpv positive throat cancer treatment.
Aim: To implement the HPV genotyping method of fresh head and neck cancer samples in our laboratory.
More than half of the patients recognized being chronic alcohol and tobacco users. Conclusions: The genotyping method was validated according to kit instructions.
Mult mai mult decât documente.
To get a general idea on the prevalence of HPV genotypes in head and neck cancer in our region we tested a very small number of samples. Ferlay J, Soerjomataram I et al.
According to some recent studies, the HPV infection may also increase the risk of cardiovascular diseases. Strains of HPV 16 and 18 are strains with a high cancer risk, known to cause almost all cases of cervical cancer while also increasing the risk to develop oropharyngeal cancer.
Comprehensive control of human papillomavirus infections and related diseases. Venuti A, Paolini F. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
Ursu RG, Danciu M et al. Paraziti intestinali noaptea J. Human papillomavirus prevalence in invasive laryngeal cancer in the United States.
Shanesmith R, Allen RA et al. Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas.
HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Garnaes E, Kiss K et al. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, the hpv positive throat cancer treatment registry-based study to date.
Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
Westra WH. Heiduschka G, Grah A et al.
Masterson L, Moualed D et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systema-tic review and meta-analysis of current clinical trials.